基于上转换纳米粒子的超灵敏免疫分析检测人血浆心肌肌钙蛋白I
本研究优化了上转换纳米粒子(UCNP)表面化学、试剂与协议,构建微孔板夹心免疫分析法检测心肌肌钙蛋白I(cTnI)。该法检出限为0.13 ng/L,空白限为0.01 ng/L,加标血浆回收率>90%,批内和批间不精密度<10%,可定量健康人血浆cTnI水平,有望识别心血管病风险患者。
要点
- UCNP免疫分析检出限0.13 ng/L,空白限0.01 ng/L。
- 加标血浆回收率>90%,批内和批间不精密度<10%。
- 该法可定量健康人血浆cTnI,有望用于心血管病风险识别。
核心结论
- UCNP免疫分析可定量健康个体血浆中预期浓度的cTnI,并可能用于识别心血管疾病风险患者。
研究设计与样本
- UCNP经两步配体交换包被聚丙烯酸并偶联单克隆抗体,采用两种捕获抗体组合的微孔板夹心免疫分析法检测cTnI,按临床与实验室标准协会指南评估。
主要发现
- 检出限为0.13 ng/L cTnI,空白限为0.01 ng/L cTnI。
- 在线性范围内加标血浆回收率>90%。
- 批内和批间不精密度<10%。
关键数值与推荐
- 检出限0.13 ng/L cTnI,空白限0.01 ng/L cTnI。
- 线性范围内加标血浆回收率>90%。
- 批内和批间不精密度<10%。
临床怎么用
- 该超灵敏cTnI免疫分析可定量健康人血浆基线cTnI水平,可能辅助识别心血管疾病风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Upconverting nanoparticles (UCNPs) are attractive reporters for immunoassays due to their excellent detectability. Assays sensitive enough to measure baseline level of cardiac troponin I cTnI in healthy population could be used to identify patients at risk for cardiovascular disease. Aiming for a cTnI assay of such sensitivity, the surface chemistry of the nanoparticles as well as the assay reagents and the protocol were optimized for monodispersity of the UCNP antibody conjugates (Mab UCNPs) and to minimize their non-specific interactions with the solid support. MATERIALS AND METHODS: UCNPs were coated with poly(acrylic acid) via two-step ligand exchange and conjugated with monoclonal antibodies. The conjugates were applied in a microplate-based sandwich immunoassay using a combination of two capture antibodies to detect cTnI. Assay was evaluated according to guidelines of Clinical & Laboratory Standards Institute. RESULTS: The limit of detection and limit of blank of the assay were 0.13 ng/L and 0.01 ng/L cTnI, respectively. The recoveries were >90% in spiked plasma in the linear range. The within- and between-run imprecisions were <10%. CONCLUSION: The results demonstrate that UCNPs enable quantification of cTnI concentrations expected in plasma of healthy individuals and could be used to identify patients at risk for cardiovascular disease.
引用
- Raiko K, Lyytikäinen A, Ekman M, et al. Supersensitive photon upconversion based immunoassay for detection of cardiac troponin I in human plasma. Clin Chim Acta. 2021. PMID: 34688634. doi:10.1016/j.cca.2021.10.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。